scholarly journals P09.01 Phase I/II Study of Temozolomide Plus Nimustine Chemotherapy for Recurrent Malignant Gliomas: Kyoto Neuro-oncology Group

2017 ◽  
Vol 19 (suppl_3) ◽  
pp. iii70-iii70
Author(s):  
T. Aoki ◽  
Arakawa ◽  
Ueba ◽  
Oda ◽  
Nishida ◽  
...  
Keyword(s):  
Phase I ◽  
Malignant Gliomas ◽  
Oncology Group

scholarly journals ACTR-05. PHASE I/II STUDY OF TEMOZOLOMIDE PLUS NIMUSTINE CHEMOTHERAPY FOR RECURRENT MALIGNANT GLIOMAS: KYOTO NEURO-ONCOLOGY GROUP

2016 ◽  
Vol 18 (suppl_6) ◽  
pp. vi2-vi2
Author(s):  
Tomokazu Aoki ◽  
Yoshiki Arakawa ◽  
Tetsuya Ueba ◽  
Masashi Oda ◽  
Namiko Nishida ◽  
...  
Keyword(s):  
Phase I ◽  
Malignant Gliomas ◽  
Oncology Group

scholarly journals ACTR-25. PHASE I/II STUDY OF TEMOZOLOMIDE PLUS NIMUSTINE CHEMOTHERAPY FOR RECURRENT MALIGNANT GLIOMAS: KYOTO NEURO-ONCOLOGY GROUP

2017 ◽  
Vol 19 (suppl_6) ◽  
pp. vi6-vi6
Author(s):  
Tomokazu Aoki ◽  
Yoshiki Arakawa ◽  
Tetsuya Ueba ◽  
Masashi Oda ◽  
Namiko Nishida ◽  
...  
Keyword(s):  
Phase I ◽  
Malignant Gliomas ◽  
Oncology Group

scholarly journals ACTR-62. PHASE I/II STUDY OF TEMOZOLOMIDE PLUS NIMUSTINE CHEMOTHERAPY FOR RECURRENT MALIGNANT GLIOMAS: KYOTO NEURO-ONCOLOGY GROUP

2018 ◽  
Vol 20 (suppl_6) ◽  
pp. vi25-vi25
Author(s):  
Tomokazu Aoki ◽  
Yoshiki Arakawa ◽  
Tetsuya Ueba ◽  
Masashi Oda ◽  
Namiko Nishida ◽  
...  
Keyword(s):  
Phase I ◽  
Malignant Gliomas ◽  
Oncology Group

scholarly journals Phase I/II Study of Temozolomide Plus Nimustine Chemotherapy for Recurrent Malignant Gliomas: Kyoto Neuro-oncology Group

2017 ◽  
Vol 57 (1) ◽  
pp. 17-27 ◽  
Author(s):  
Tomokazu AOKI ◽  
Yoshiki ARAKAWA ◽  
Tetsuya UEBA ◽  
Masashi ODA ◽  
Namiko NISHIDA ◽  
...  
Keyword(s):  
Phase I ◽  
Malignant Gliomas ◽  
Oncology Group

scholarly journals Phase I/II Study of Osimertinib With Bevacizumab in EGFR-mutated, T790M-positive Patients With Progressed EGFR-TKIs: West Japan Oncology Group 8715L (WJOG8715L)

2019 ◽  
Vol 20 (4) ◽  
pp. e492-e494 ◽  
Author(s):  
Hiroaki Akamatsu ◽  
Shunsuke Teraoka ◽  
Satoshi Morita ◽  
Nobuyuki Katakami ◽  
Motoko Tachihara ◽  
...  
Keyword(s):  
Phase I ◽  
Oncology Group ◽  
Egfr Mutated ◽  
Egfr Tkis

scholarly journals Phase I and Pharmacokinetic Study of Sunitinib in Pediatric Patients with Refractory Solid Tumors: A Children's Oncology Group Study

2011 ◽  
Vol 17 (15) ◽  
pp. 5113-5122 ◽  
Author(s):  
Steven G. DuBois ◽  
Suzanne Shusterman ◽  
Ashish M. Ingle ◽  
Charlotte H. Ahern ◽  
Joel M. Reid ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Pharmacokinetic Study ◽  
Pediatric Patients ◽  
Oncology Group ◽  
Oncology Group Study

807 Phase I trial of cisplatin, etoposide and CPT-11 triplet in patients with advanced stage SCLC. A hellenic cooperative oncology group study

2003 ◽  
Vol 1 (5) ◽  
pp. S242-S243
Author(s):  
E. Briasoulis ◽  
E. Samantas ◽  
H. Kalofonos ◽  
D. Skarlos ◽  
C. Christodoulou ◽  
...  
Keyword(s):  
Phase I ◽  
Phase I Trial ◽  
Advanced Stage ◽  
Oncology Group ◽  
Oncology Group Study
Sign in / Sign up

Export Citation Format

Share Document